Prostatype Genomics presents Interim Report for the period 1 July to 30 September 2021
Prostatype Genomics presents Quarterly report for the third quarter of 2021. The Report is available on the Company's home page.Quarter 3 (1 July – 30 September 2021 compared with 1 July – 30 September 2020) summarized · Net sales amounted to 426 (556) TSEK. · Net revenue amounted to 0 (15) TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -3 613 (-3 555) TSEK. · Cash flow from current operations in the quarter amounted -3 831 (-3 782). · Total cash flow for the period amounted to 18 888 (-4 181) TSEK. · Earnings per share